Results 101 to 110 of about 130,554 (162)

The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients

, 1998
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterized by a lifelong elevation in the concentration of low-density lipoprotein (LDL) bound cholesterol in blood by cholesterol deposits and by early coronary artery ...
RIVASI P., PIZZALA, ROBERTO, TOMASI A., CACCIAVILLANI G., BARICCHI R.   +4 more
core  

[Correction: State of the art: lipoprotein apheresis]. [PDF]

Dtsch Med Wochenschr, 2023
Schatz U, Schettler VJJ, Julius U.
europepmc   +1 more source

Lipoprotein apheresis: a Hellenic consensus on its clinical use

Hellenic Journal of Cardiology, 2021
Genovefa Kolovou, Vana Kolovou, Helen Bilianou, Georgios Goumas, Stefanos Foussas, Eirini Grapsa, Anastasia Garoufi, Georgios Karavolias, Sophie Mavrogieni, Andreas Melidonis, Haralampos Milionis, Loukianos Rallidis, Dimitris Richter, Ioannis Skoumas, Dimitris Tousoulis, Charalambos Vlachopoulos, Evangelos Liberopoulos   +16 more
doaj   +1 more source

Low-density lipoprotein apheresis shows a rapid response to proteinuria due to C3 glomerulonephritis: a case report and literature review

Renal Replacement Therapy
Background C3 glomerulonephritis (C3GN) is a rare renal disorder caused by dysregulation of the alternative complement pathway, resulting in abnormal C3 activation and deposition.
Hideki Matsumura, Yuko Fujii, Tomoko Tanaka, Maki Kagitani, Akira Ashida   +4 more
doaj   +1 more source

Population Pharmacokinetics and Exposure‐Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia

CPT: Pharmacometrics & Systems Pharmacology
Evinacumab, an angiopoietin‐like 3 (ANGPTL3) inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C), independent of low‐density lipoprotein receptor, in patients with homozygous familial hypercholesterolemia (HoFH).
Sébastien Bihorel, Robert Dingman, Jeanne Mendell, Yuhuan Wang, Poulabi Banerjee, Robert Pordy, John D. Davis, A. Thomas DiCioccio, Lutz Harnisch   +8 more
doaj   +1 more source

Comparison of plasma separation using centrifugation or filtration for MONET lipoprotein apheresis in patients with cardiovascular disease and severe dyslipidemia. [PDF]

Ther Apher Dial, 2022
Waitz G, Atiye S, Gauly A, Prophet H.
europepmc   +1 more source

Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function. [PDF]

Ther Apher Dial, 2022
Muso E, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Saito T, Mune M, Sugiyama S, Iino Y, Hirano T, Hattori M, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Oda H, Mori K, Kimura H, Ito O, Nishiyama A, Maruyama S, Inagi R, Fujimoto S, Tsukamoto T, Suzuki Y, Honda H, Babazono T, Tsuruya K, Yuzawa Y.   +31 more
europepmc   +1 more source

Switching from lipoprotein apheresis to evolocumab in FH siblings on hemodialysis: case reports and discussion. [PDF]

CEN Case Rep, 2021
Ishii T, Ogura M, Nakamori H, Hori M, Harada-Shiba M, Tamura K, Oyama K.   +6 more
europepmc   +1 more source

Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns

, 1996
Lipid apheresis, a new extracorporeal procedure based on plasma delipidation and showing promise as a possible treatment for atherosclerosis, was recently reported for the first time from this laboratory [Cham et al., J Clin Apheresis 10:61-69, 1995]. In
Cham BE, Kostner KM, Fang NX, Mahon MG, Dwivedy AK, Shafey TM   +2 more
core  

Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina

Revista Portuguesa de Cardiologia, 2022
Francesco Sbrana, Beatrice Dal Pino, Giovanni Donato Aquaro, Federico Bigazzi, Giuseppe Vergaro, Tiziana Sampietro   +5 more
doaj   +1 more source